Imricor Medical Systems, Inc.ASX: IMR

2026 Q3 Form 10-Q

· Issued by Imricor Medical Systems, Inc. via ASX

Filed with ASX · · 46 pages · English

Summary by 6ix AI

The report includes condensed consolidated financial statements, management's discussion, and analysis of financial condition and results of operations. It highlights significant figures such as total assets, liabilities, and stockholders' equity, along with revenues and net loss for the quarter. The document is prepared in accordance with U.S. GAAP and includes unaudited financial information.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2026 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...

Imricor Medical Systems, Inc. on 6ix

Earlier from Imricor Medical Systems

Later from Imricor Medical Systems

All Imricor Medical Systems news releases